Morepen Laboratories Limited (BOM:500288)

Market Cap	34.08B
Revenue (ttm)	17.84B
Net Income (ttm)	1.26B
Shares Out	547.95M
EPS (ttm)	2.40
PE Ratio	25.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	277,173
Average Volume	525,376
Open	52.32
Previous Close	52.22
Day's Range	52.00 - 53.12
52-Week Range	41.66 - 100.80
Beta	1.45
RSI	71.98
Earnings Date	May 5, 2025

About Morepen Laboratories

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermome...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 2,152
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500288

Financial Performance

In 2023, Morepen Laboratories's revenue was 17.02 billion, an increase of 19.68% compared to the previous year's 14.22 billion. Earnings were 961.60 million, an increase of 148.63%.